Hillhouse Capital Invests $35M Series A+ Round In Chinese Biopharmaceutical Firm Elpiscience

Chinese biotech company Elpiscience Biopharmaceuticals Co., has completed US$35 million series A+ round of financing, led by Hillhouse Capital, with participation from CDH Investments and Lilly Asia Ventures (LAV). The one-year-old company has secured an investment amount of US$55 million in total, said the company to China Venture, including a series A round led by […]

Hillhouse Capital Invests $35M Series A+ Round In Chinese Biopharmaceutical Firm Elpiscience appeared first on China Money Network.

Read the original article: China Money Network